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Azoles affect the steroid balance in all biological systems and may therefore be called
endocrine disrupters. Lanosterol 14-demethylase (CYP51) is an enzyme inhibited by azoles.
Only few data have been reported showing their inhibitory potency since an assay in an in
vitro system is not available so far. In the present work an inhibition assay using human
recombinant CYP51, coexpressed with human P450 oxido-reductase by the baculovirus/insect
cell expression system, and LC-MS/MS as analytical method is described. Atmospheric
pressure photoionization (APPI) and atmospheric pressure chemical ionization (APCI) sources
were used with a triple quadrupole mass spectrometer to compare quantitation of lanosterol
(substrate) and 4,4-dimethyl-5-cholesta-8,14,24-triene-3-ol (FF-MAS) (product of CYP51)
with d6-2,2,3,4,4,6-cholesterol (d6-cholesterol) as internal standard. Optimization of analytical
parameters resulted in a LC-APPI-MS/MS method with a LOQ of 10 pg on column for
FF-MAS. The sensitivity of the method (LOD 0.5 ng/ml) makes it possible to analyze
supernatants of inhibition experiments after precipitation of proteins by isopropanol without
any sample enrichment. The coefficient of variation of the analytical method was 20% (n 
5) for FF-MAS, lanosterol and d6-cholesterol. The external calibration curve was linear from 1
to 10,000 ng/ml with R2  0.999 and an accuracy of 94–115%. Compared with APCI, APPI
provides a ten- to 500-fold increase in sensitivity for the analytes in this study. IC50 values of
epoxiconazole and miconazole—two widely used azole fungicides used in agriculture and in
human medicine, respectively—were 1.95 M and 0.057 M. (J Am Soc Mass Spectrom 2004,
15, 1216–1221) © 2004 American Society for Mass SpectrometryAzoles (imidazoles and triazoles) exhibit an anti-fungal activity and are widely used as fungi-cides in agriculture as antimycotic agents but
also as medical drugs for tumor chemotherapy. These
different applications have been discussed for the ob-
served increase of resistance of human fungal infections
against azole treatment. Furthermore, azoles are sug-
gested as a new group of endocrine active agents
disturbing the biosynthesis of steroids by inhibition of
cytochrome P450 enzymes like aromatase (CYP19) [1]
and lanosterol 14-demethylase (CYP51).
The antifungal activity of azoles is based on the
inhibition of sterol biosynthesis, particularly catalyzed
by lanosterol 14-demethylase (CYP51), a widely dis-
tributed and highly conserved cytochrome P450-depen-
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doi:10.1016/j.jasms.2004.04.036dent monooxygenase [2]. Inhibition results in a de-
crease of ergosterol and increase of chitin which are
critical components of the fungal cell wall [3]. In mam-
mals CYP51 catalyzes the oxidative demethylation of
lanosterol (Scheme 1). The resulting sterols in testis,
sperm, and follicle are named meiosis activating sterols
(MAS) [4, 5]. Therefore the inhibition of CYP51 by
azoles may also influence the endocrine balance in
mammals as previously suggested [6].
No assay for testing the inhibitory effect of azoles to
CYP51 comparable to that of CYP19 is available. Such a
method is necessary to test azoles applied as fungicides
agriculturally or in human medicine for their inhibitory
potency of CYP51. It would further be useful for the
development of new substances, designed to inhibit
specifically only CYP51.
Lanosterol and its metabolites were predominantly
quantitated directly or after derivatization by gas chro-
matography mass spectrometry (GC-MS) [7, 8]. If
amounts of about 1 ng of each steroid were available,r Inc. Received February 18, 2004
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phase high performance liquid chromatography
(HPLC) and detected using a diode array detector [9].
The detection of steroids like cholesterol and cholesterol
oxides by HPLC mass spectrometry (HPLC-MS) using
an atmospheric pressure chemical ionization (APCI)
source are published [10]. APCI has to be used instead
of electrospray ionization (ESI) since steroids are too
lipophilic and exhibit no moieties for protonation or
deprotonation processes typical for ESI. The distinction
of ergosterol from lanosterol by APCI and tandem mass
spectrometry was reported with a limit of detection in
the low ng/ml range [11]. Here we present a LC-
MS/MS method using an atmospheric pressure photo-
ionization source for quantitation of lanosterol and
FF-MAS in the low ng/ml range. It was tested in
inhibition experiments of azoles with a human recom-
binant CYP51 enzyme. To our knowledge, this is the
first time that an assay based on a human recombinant
CYP51 enzyme combined with an APPI-MS/MS
method is used for quantitation of CYP51 inhibition by
azoles.
Materials and Methods
Chemicals and Reagents
Epoxiconazole was a kind gift from the Swiss Federal
Research Station, Wa¨denswil, Switzerland. 4,4-Dimeth-
yl-5-cholesta-8,14,24-triene-3-ol (FF-MAS) was a kind
gift from NovoNordisk (Gentofte, Denmark). HPLC
grade water was from Roth (Karlsruhe, Germany). All
other chemicals were from Sigma/Fluka (Taufkirchen,
Germany). All solvents used were HPLC grade or
better.
Human lanosterol 14-demethylase (CYP51, Acces-
sion No. U23942) coexpressed with human P450 reduc-
tase (baculovirus/insect cell-expressed) was con-
structed using vectors and viral DNA from PharMingen
(San Diego, CA) according to the manufacturer’s in-
structions. Enzyme expression was carried out in spin-
ner flasks of BTI-TN-5B1-4 insect cells. Infection time
was for 48 h. Membrane fraction from insect cells was
prepared according to standard methods with slight
modification [12].
Scheme 1. Demethylation of lanosterol to FF-MAS catalyzed by
CYP51.Inhibition Assay
Stock solutions of lanosterol (1 mM) and Triton X-100
(16 mg/ml) were prepared in isopropanol. Stock solu-
tions and dilution series of azoles were prepared in
ethanol.
Lanosterol (11.9 M) was incubated in 0.1 M potas-
sium phosphate buffer (pH 7.4) containing 1.1 mM
NADP, 2.8 mM glucose-6-phosphate, 0.34 U/ml glu-
cose-6-phosphate dehydrogenase, 2.8 mM magnesium
chloride, 1 l of azole dilution and 2 l of the Triton
X-100 stock solution in a total volume of 84 l in all
experiments. The reaction mixture was preincubated
for 5 min at 37 °C and the reaction was started by
addition of the enzyme (0.1 M CYP51). After 40 min at
37 °C 80 l of isopropanol containing internal standard
(5 M) were added to stop the reaction. Protein was
removed by centrifugation at 15,000 g for 5 min. The
supernatant was analyzed by LC-MS/MS.
Optimization of Mass Spectrometry Methods
Each method (LC-APCI-MS/MS, LC-APPI-MS/MS)
was optimized separately with respect to sensitivity,
analyte identification, and quantitative measurement.
Infusion experiments to examine ionization and frag-
mentation patterns of the analytes were carried out with
both sources. A syringe pump (Single Syringe Pump 11,
Harvard Apparatus Inc., Holliston, MA) was used to
provide a constant analyte infusion (300 l/min) into
the LC eluent via a T-connection. Analyte concentra-
tions were chosen in the range of 5–100 ng/l to obtain
a constant signal in the Q1 scan mode. Basic source and
MS parameters such as declustering potential (DP),
focussing potential (FP), collision energy (CE), and exit
potential (CXP) were optimized using the quantitative
optimization function of Analyst version 1.3.1. (Applied
Biosystems, Darmstadt, Germany).
Quantitation
To quantify lanosterol, FF-MAS and d6-cholesterol 10 l
of the supernatants were injected on a Symmetry Shield
C8 HPLC column (3.0 mm  150 mm; 5 m; Waters,
Eschborn, Germany) using an Agilent 1100 (Wald-
bronn, Germany) autosampler and an Agilent 1100
HPLC-pump. The samples were separated by gradient
elution with water (Solvent A) and MeOH (Solvent B)
using the following conditions: 50% A isocratic for 1
min, linear to 2% A within 1 min, and isocratic for 8 min
at 2% A with a flow rate of 600 l/min. For APPI
measurements toluene was used as dopant with a flow
rate of 42 l/min. The dopant was delivered to the
APPI source with a syringe pump and a 50 ml gastight
glass syringe (Hamilton Company, Reno, NV). The
HPLC system was directly coupled to a triple stage
quadrupole mass spectrometer (API 3000, Applied Bio-
systems) equipped with an atmospheric pressure chem-
ical ionization or an atmospheric pressure photoioniza-
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mode at a vaporizer temperature of 400 °C. For APCI a
needle current of 3 and for APPI a source voltage (IS) of
2000 was applied. Spectral data were recorded with N2
as collision gas (CAD  4) in the multiple reaction
monitoring (MRM) mode with a dwell time of 500 ms
for each transition monitoring the following MS/MS
ion-transitions.
MS/MS-Transitions, Declustering Potential
and Collision Energy Used
Transition Compound DP [V] CE [V]
[MHH2O]
 3
409.53109.1 Lanosterol (quantifier) 41 43
409.5395.3 Lanosterol (qualifier) 41 51
375.43167.5 d6-Cholesterol (quantifier,
internal standard)
36 31
375.4395.2 d6-Cholesterol (qualifier,
internal standard)
36 55
393.5368.9 FF-MAS (quantifier) 46 55
393.5355.2 FF-MAS (qualifier) 46 63
Quantitation of FF-MAS was based on calibration
curves obtained after addition of known amounts of
FF-MAS (1–10,000 ng/ml) to incubation samples con-
taining heat-deactivated CYP51. Calibration curves
were calculated from seven duplicate data points using
Analyst 1.3.1.
Data Evaluation
The concentration range to be tested in the main exper-
iment was defined in a dose-finding study with inhib-
itor concentration steps of factors of ten.
For the main experiment, at least seven logarithmi-
cally spaced concentrations were used, with the ex-
pected IC50 at the median. Dose responses were run in
duplicates. A full analytical method for the quantitation
of amounts of FF-MAS produced for the described
inhibition studies was developed.
The area of FF-MAS corrected by the internal stan-
dard (relative area) was plotted against the log (base 10)
of the concentration of azole. Four parameters were
estimated by fitting the two replicate area data sets to a
probit curve: The FF-MAS relative area at azole concen-
tration 0 and , the relative area at half maximum
inhibition, and the slope of the probit curve. Statistical
analysis was performed by a nonlinear mixed-effects
model fit by maximum likelihood run on the statistics
software “R”. A random error was attributed to the
FF-MAS relative area at azole concentration 0, to ac-
count for differences between replicates for the extrap-
olated null measurement.
R is a language and environment for statistical
computing and graphics. It is available as Free Software
under the terms of the Free Software Foundation’s
GNU General Public License in source code form. It
compiles and runs on a wide variety of UNIX platformsand similar systems (including FreeBSD and Linux),
Windows, and MacOS. Information on download is
available at http://www.r-project.org.
Results
Characterization of CYP51
Membrane fractions of baculovirus expressed CYP51
were tested for the conversion of [3H]-lanosterol to
FF-MAS using previously described methods [13]. The
turnover number using 15 M lanosterol was 0.9 pmol/
min/pmol P450.
Identification and Quantitation of FF-MAS
Due to their lipophilic character the ionization of lanos-
terol, FF-MAS and d6-cholesterol was performed with
atmospheric pressure chemical ionization or atmo-
spheric pressure photoionization. Collision-induced
dissociation (CID) of [M  H  H2O]
 of all com-
pounds provided a number of characteristic fragmen-
tations in spite of the low collision energies used
(Figures 1, 2, and 3). For quantitation of FF-MAS in
biological solutions, a method based on HPLC separa-
Figure 1. Product ion spectrum of lanosterol.
Figure 2. Product ion spectrum of FF-MAS.
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oped with the most intensive product ions m/z 68.9 [M
 C24H37O]
 and m/z 55.2 [M  C25H39]
 for FF-MAS
and m/z 167.5 [M  C15H28]
 for d6-cholesterol used as
internal standard. Calibration curves were linear in the
range of 1–10,000 ng/ml with R2  0.999. The accuracy
for FF-MAS in incubation solution were within 100 
20% for n  5 analyses of 10 ng/ml (Table 1).
With the APPI source, the limit of quantitation (LOQ)
could be reduced by a factor of 10 for lanosterol and
FF-MAS (5 ng/ml and 1 ng/ml respectively) and by a
factor of 500 for d6-cholesterol (0.1 ng/ml) compared to
APCI (Table 1). Thus, only very low amounts of about
8 pmol of the recombinant enzyme are required.
Inhibition of CYP51 by Azoles
Inhibition studies were carried out with two azoles.
Epoxiconazole is used as a fungicide, miconazole is
used in human medicine to treat fungal infections e.g.,
Figure 3. Product ion spectrum of d6-cholesterol.
Table 1. Analytical data of 3 steroids applying LC-APCI-MS/
MS or LC-APPI-MS/MS
APCI APPI
Lanosterol LOD [ng/ml] 10 0.5
LOQ [ng/ml] 50 5
dynamic range [ng/ml] 50–1 000 5–10 000
accuracy 80–120% 85–100%
precision (10  LOQ) 16% 4%
regression factor 0.975 0.999
FF-MAS LOD [ng/ml] 5 0.5
LOQ [ng/ml] 10 1
dynamic range [ng/ml] 10–1 000 1–10 000
accuracy (10  LOQ) 80–100% 94–115%
precision (10  LOQ) 14% 8%
regression factor 0.998 0.999
d6-Cholesterol LOD [ng/ml] n.d. n.d.
LOQ [ng/ml] 50 0.1
dynamic range [ng/ml] 50–5 000 0.1–5 000
accuracy (10  LOQ) 91–119% 81–111%
precision (10  LOQ) 10% 7%
regression factor 0.999 0.998of the skin or of the intestine. For epoxiconazole an IC50
value of 1.95 M (factor 1.51 as geometric standard
error), and for miconazole an IC50 value of 0.057 M
(geometric standard error  1.24) were calculated.
Discussion
The described inhibition assay uses conditions that
were optimized for the comparison of different inhibi-
tors. Substrate concentration was chosen to achieve
high turn-over rates for lanosterol under optimal incu-
bation conditions for CYP51 activity. Since lanosterol
solubility is limited in aqueous systems and CYP51
activity decreases with increasing amounts of organic
solvents, a compromise had to be found. More than
optimal amounts of organic solvent were needed to
keep lanosterol reproducibly in solution. To limit the
required amount of alcohol, suboptimal lanosterol con-
centrations were used. This resulted in reproducible
turnover rates below Km, but required a highly sensitive
analytical method to detect FF-MAS as the product of
the enzymatic reaction.
Neutral sterols like lanosterol and FF-MAS were
typically identified and quantitated in biological sam-
ples by GC-MS with or without derivatization [14, 15].
The use of GC-MS requires a time consuming sample
work up to get volatile analytes and solvents. This is
especially complicated for samples in an aqueous ma-
trix. Therefore, and because of the importance of sterols
in medical applications, LC-MS based methods have to
be developed to analyze sterols in biological samples.
The same holds for the analysis of environmental water
samples collected near farmlands and sewage plants,
where sterols are discussed as important endocrine
disrupters threatening the ecosystems [16].
The disadvantage of LC-MS for the analysis of neu-
tral sterols is the poor ionization efficiency by electro-
spray ionization. Lanosterol, FF-MAS, and d6-choles-
terol could not be ionized at concentrations below 100
ng/l (data not shown). To improve ion formation in
the ESI mode analytes have to be derivatized i.e., with
electrophoric labels like pentafluorobenzyl chloride
which generally requires sample work up comparable
to the GC-MS procedure. Another possibility is the use
of sources which allow the ionization of more lipophilic
compounds like the atmospheric pressure chemical
ionization (APCI) source [17, 18].
Previously, the atmospheric pressure photoioniza-
tion source independently developed by Bruins and Sy-
age, was used for ionization of corticosteroids by Greig et
al. showing a higher sensitivity compared to ESI and
APCI [19, 20]. Greig et al. used a Fourier transform ion
cyclotron mass spectrometer (FTICRMS) which allows
very sensitive analyses in the high resolution mode [19].
Another possibility to get highest sensitivity with a
more common mass selective detector is the use of a
triple quadrupole mass spectrometer. Collision induced
dissociation (CID) creates characteristic fragments that
can be analyzed in the third quadrupole. The product
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for CID spectra. Usually, few characteristic fragment
ions are produced by lower energies compared to
electron impact (EI) spectra. In the case of steroids the
fragment pattern is very similar to EI or to particle beam
spectra of sterols as published by Byskov et al. [21]. CID
spectra similar to ours have previously been published
for 6-OH-hydrocortisone and testosterone [22, 23]. The
fragments of the sterols presented in Figure 1–3 are
calculated as described for particle beam spectra of
FF-MAS and lanosterol where a side chain fragmenta-
tion was observed [21]. The product ion spectrum of
ergosterol also shows a prominent m/z 69 identified as
[(CH3)2CHCH¢CH]
 generated by CID of the side
chain [24]. In addition, for sterols like estrone or testos-
terone, a fragmentation in the C-ring of the steroid has
been reported after collision induced dissociation as
suggested in Figures 1 and 3 [17, 25].
For the described application highest ionization effi-
ciency is achieved by the APPI source. In combination
with the use of the multiple reaction monitoring (MRM)
scan mode, which provides very low noise levels, the
detection and quantitation in the low ng/ml range (0.1–5)
is possible. These results are comparable to the electron
capture (EC) derivatization procedure for estrone [17].
For lanosterol, FF-MAS and d6-cholesterol the use of the
APPI source instead of the APCI source resulted in a 10-
to 500-fold lower LOD and LOQ (Table 1). Greig et al.
also reported a better signal to noise using APPI versus
APCI but did not provide quantitative data [19].
In contrast to FTICRMS, the APPI-MRM method is
useful for quantitation in a wide dynamic range (Table
1). Compared to EC-APCI, only a simple sample work
up with a precipitation of proteins by centrifugation is
necessary. This cleaning step is efficient for highest sensi-
tivity, reproducibility and accuracy better than 100 20%
at LOQ for all analytes tested so far. The measurements
with the APPI source were more precise than those with
APCI using identical chromatographic conditions. This
might be attributed to the fact, that ionization efficiency is
higher for APPI. Ionization efficiency is defined as the
relative amount of ions formed in comparison to the
total amount of analyte present in the source. We assume
that the average run-to-run difference in ionization effi-
ciency per amount of analyte present is equal/comparable
for both sources. In this case, the average error relative
to the amount of ionized molecules decreases with
increasing ionization efficiency. This is in accordance
with higher precision for APPI as compared to APCI.
For the use of the APPI-MS/MS method in biological
matrix, incubations with lanosterol and d6-cholesterol
were performed using a NADPH generating system
and a human recombinant lanosterol demethylase
(CYP51). With this method inhibitory activity of azoles
on CYP51 could be determined (Figure 4). The quanti-
tation of FF-MAS in supernatants of incubations shows
clearly that the baculovirus expressed CYP51 forms
FF-MAS with a similar turnover number of 0.1 pmolproduct/min  pmol protein as seen with an assay
using [3H]-lanosterol (data not shown).
To perform inhibition experiments of CYP51 by
azoles a low LOQ and a wide dynamic range for
FF-MAS is required to get suitable data to calculate IC50
values of azole derivatives. The concentrations of FF-
MAS were in a dynamic range of 1 to 10,000 ng/ml for
FF-MAS determined by calibration curves. Only the
ratio of the peak areas of FF-MAS and d6-cholesterol (
relative peak area) were used for calculation of IC50
values. This was possible, since a linear correlation
between relative areas and concentration could be proven
by the measurement of calibration curves (n  3).
Due to the structural similarity of lanosterol with
FF-MAS a completely resolved separation by HPLC of
the analytes was not achieved. However, an unequivo-
cal distinction of both substances was possible taking
advantage of the specificity of the triple quadrupole
mass spectrometer as detector since the characteristic
MRM transitions are different for FF-MAS, lanosterol
and d6-cholesterol. With the presented LC-APPI-
MS/MS method the sterols have to be separated only
from buffer salts used in incubations due to the sup-
pression of ionization by such high buffer concentra-
tions. This results in short run times of 10 min
compared with HPLC-UV separations. When high con-
centrations of one analyte were injected, the two other
substances were not detectable, clearly demonstrating
that no artefacts were formed during the ionization
process and that the standards were pure. A matrix
Figure 4. Separations of FF-MAS in incubations of lanosterol
with CYP51 performed with different concentrations of epoxicon-
azole as inhibitor of CYP51 (a) 0.01 M; (b) 3 M; (c) 100 M).
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observed. In connection with a well plate autosampler a
fully automated assay with high sample throughput
will be possible.
Due to its sensitivity, the method is not only appli-
cable for the described assay using recombinant CYP51
but also for biological systems with lower CYP51 activ-
ity e.g., in microsomes or fungi. Furthermore, no expen-
sive radioactive substrate is needed to perform this
assay and analytes may be quantitated in every kind of
sample like blood or urine. The LC-APPI-MS/MS
method should also be useful for other sterols which
have to be quantitated i.e., in river water near sewage
plants or pastures of cattle for ecotoxicological risk assess-
ments of a putative endocrine disrupting potential.
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